返回 
加入收藏
日本儿童药定价及价格激励政策对我国的启示
x
请在关注微信后，向客服人员索取文件
| 篇名： | 日本儿童药定价及价格激励政策对我国的启示 |
| TITLE： | Pediatric Drug Pricing and Price Incentive Policy in Japan and Its Enlightenment to China |
| 摘要： | 目的：借鉴日本儿童药定价及价格激励政策，为我国儿童药价格体系的完善提供参考。方法：分析日本药品定价策略，总结日本儿童药价格激励政策及其实施现状与效果，提出完善我国儿童药价格体系的建议。结果与结论：日本医保药品定价策略包括医保目录准入定价和医保目录内药品价格调整两种类型，其中儿童药价格激励政策主要包括儿童新药初次定价补正加算、目录内新增儿童适应证加算和其他措施（如符合条件的药品可获得间接价格补偿、卫生技术评估时要考虑儿童因素等）等。整体而言这些措施加快了日本儿童药研发上市、有效推动了日本儿童药发展。笔者建议我国应开展体现儿童药特殊性的卫生技术评估，对儿童药医保支付价格予以适当的直接价格激励，并合理制定儿童适用的药品品规的价格并给予价格激励，以促进我国儿童药的发展。 |
| ABSTRACT： | OBJECTIVE：To learn from pedia tric drug pricing and price incentive policy in Japan ，and to provide reference for the improvement of pediatric drug price system in China. METHODS ：The drug pricing strategy of Japan was analyzed ，and price incentive policy of pediatric drugs in Japan and its implementation status and effect were summarized. The suggestions of perfecting the price system of pediatric drugs in China were put forward . RESULTS & CONCLUSIONS ：The pricing strategy of medical insurance drugs in Japan included two types ，such as access pricing of medical insurance list and price adjustment of drugs in medical insurance list. Among them ，price incentive policy for pediatric drugs mainly included the premium for initial pricing of new pediatric drugs ，the premium for drugs with newly added pediatric indication included in medical insurance list and other measures（such as eligible drugs could obtain indirect price compensation ，and children ’s factors could be considered in health technology assessment ）. Overall ，these measures accelerated the R&D and marketing of Japanese pediatric drugs ，and effectively promoted the development of pediatric drugs in Japan. The author suggests that our country should carry out health technology assessment which reflects the particularity of pediatric drugs ，give appropriate direct price incentives to the payment price of pediatric drugs ，and reasonably set the price of drug specification suitable for children and give price incentives so as to promote the development of pediatric drugs in China. |
| 期刊： | 2021年第32卷第23期 |
| 作者： | 张宸，凡馨，金秋晨，陈永法 |
| AUTHORS： | ZHANG Chen，FAN Xin，JIN Qiuchen ，CHEN Yongfa |
| 关键字： | 儿童药；定价机制；价格激励政策；加算；日本 |
| KEYWORDS： | Pediatric drugs ；Pricing mechanism ；Price incentive policy ；Premium；Japan |
| 阅读数： | 282 次 |
| 本月下载数： | 11 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
